Document:

Consulting Agreement-V.T. Franzke

Exhibit 4.1(f) 
 
CONSULTING AGREEMENT 
 
AGREEMENT, effective as of the 14th day of February 2003, between Calypte Biomedical Corporation, a Delaware Corporation (the “Company”), of 1265 Harbor Parkway, Alameda, CA 94502, and
V.T. Franzke, located at 120 Adelaide Street West, Toronto Ontario M5H1T1 (“Consultant”). 
 
WHEREAS, THE Company desires the Consultant to provide consulting services to the Company pursuant hereto and Consultant is agreeable to
providing such services. 
 
NOW THEREFORE, in
consideration of the premises and the mutual promises set forth herein, the parties hereto agree as follows: 
 
1. Consultant shall serve as a consultant to assist the Company in general corporate activities including but not limited
to the following areas: 
 
(a)
Arranging synergistic marketing relationship introductions such as for public service announcements. 
 
2. Term: The Company shall be entitled to Consultant’s services for reasonable times when and to the extent requested
by, and subject to the direction of Mr. Cataldo. The term of this Consulting Agreement began as of the date of this Agreement, and shall terminate on July 14, 2003. 
 
3. Reasonable travel and other expenses necessarily incurred by Consultant to render such
services, and approved in advance by the Company, shall be reimbursed by the Company promptly upon receipt of proper statements, including appropriate documentation, with regard to the nature and amount of those expenses. Those statements shall be
furnished to the Company monthly at the end of each calendar month in the Consulting Period during which any such expenses are incurred. Company shall pay expenses within fifteen (15) business days of the receipt of a request with appropriate
documentation. 
 
4. The Company
will immediately grant Consultant a warrant to purchase Five million (5,000,000) shares of the common stock of the Company at an exercise price of $0.05 per share. The warrant expires on May 14, 2003. 
 
5. The consultant will provide to
Calypte’s Executive Chairman a written report of services rendered and results thereof no less than quarterly and that report will be issued within 30 days of quarter end (e.g. April 30, 2003 for the period ended March 31, 2003 and then
within 30 days of the conclusion of the agreement). 
 
6. It is the express intention of the parties that the Consultant is an independent contractor and not an employee or agent of the Company. Nothing in this agreement shall be interpreted or construed as creating or

establishing the relationship of employer and employee between the Consultant and the
Company. Both parties acknowledge that the Consultant is not an employee for state or federal tax purposes. The Consultant shall retain the right to perform services for others during the term of this agreement. 
 
6.1 The consulting services shall not involve
and the Consultant is not engaged in services in connection with the offer or sale of securities in a capital-raising transaction for Calypte, and further, the Consultant does not and will not directly or indirectly promote or maintain a market for
Calypte’s securities. 
 
7.
Neither this agreement nor any duties or obligations under this agreement may be assigned by the Consultant without the prior written consent of the Company. 
 
8. This agreement may be terminated upon ten (10) days written notice by the Company. Notwithstanding any termination, the
consideration, as outlined in Section 4, shall be earned in full by the Consultant upon the execution of this agreement. 
 
9. Any notices to be given hereunder by either party to the other may be given either by personal delivery in writing or
by mail, registered or certified, postage prepaid with return receipt requested. Mailed notices shall be addressed to the parties at the addressed appearing in the introductory paragraph of this agreement, but each party may change the address by
written notice in accordance with the paragraph. Notices delivered personally will be deemed communicated as of actual receipt; mailed notices will be deemed communicated as of two days after mailing. 
 
10. This agreement supersedes any and all
agreements, either oral or written, between the parties hereto with respect to the rendering of services by the Consultant for the Company and contains all the covenants and agreements between the parties with respect to the rendering of such
services in any manner whatsoever. Each party to this agreement acknowledges that no representations, inducements, promises, or agreements, orally or otherwise, have been made by any party, or anyone acting on behalf of any party, which are not
embodied herein, and that no other agreement, statement, or promise not contained in this agreement shall be valid or binding. Any modification of this agreement will be effective only if it is in writing signed by the party to be charged.

 
11. This agreement will be
governed by and construed in accordance with the laws of the State of California, without regard to its conflicts of laws provisions; and the parties agree that the proper venue for the resolution of any disputes hereunder shall be Alameda County,
California. 
 
12. For purposes of
this Agreement, Intellectual Property will mean (i) works, ideas, discoveries, or inventions eligible for copyright, trademark, patent or trade secret protection; and (ii) any applications for trademarks or patents, 

issued trademarks or patents, or copyright registrations regarding such items. Any items
of Intellectual Property discovered or developed by the Consultant (or the Consultant’s employees) during the term of this Agreement will be the property of the Consultant, subject to the irrevocable right and license of the Company to make,
use or sell products and services derived from or incorporating any such Intellectual Property without payment of royalties. Such rights and license will be exclusive during the term of this Agreement, and any extensions or renewals of it. After
termination of this Agreement, such rights and license will be nonexclusive, but will remain royalty-free. Notwithstanding the preceding, the textual and/or graphic content of materials created by the Consultant under this Agreement (as opposed to
the form or format of such materials) will be, and hereby are, deemed to be “works made for hire” and will be the exclusive property of the Company. Each party agrees to execute such documents as may be necessary to perfect and preserve
the rights of either party with respect to such Intellectual Property. 
 
13. The written, printed, graphic, or electronically recorded materials furnished by the Company for use by the Consultant are Proprietary Information and are the property of the Company. Proprietary
Information includes, but is not limited to, product specifications and/or designs, pricing information, specific customer requirements, customer and potential customer lists, and information on Company’s employees, agent, or divisions. The
Consultant shall maintain in confidence and shall not, directly or indirectly, disclose or use, either during or after the term of this agreement, any Proprietary Information, confidential information, or know-how belonging to the Company, whether
or not is in written form, except to the extent necessary to perform services under this agreement. On termination of the Consultant’s services to the Company, or at the request of the Company before termination, the Consultant shall deliver to
the Company all material in the Consultant’s possession relating to the Company’s business. 
 
14. The obligations regarding Proprietary Information extend to information belonging to customers and suppliers of the
Company about which the Consultant may have gained knowledge as a result of performing services hereunder. 
 
15. The Consultant shall not, during the term of this agreement and for a period of one year immediately after the
termination of this agreement, or any extension of it, either directly or indirectly (a) for purposes competitive with the products or services currently offered by the Company, call on, solicit, or take away any of the Company’s customers or
potential customers about whom the Consultant became aware as a result of the Consultant’s services to the Company hereunder, either for the Consultant or for any other person or entity, or (b) solicit or take away or attempt to solicit or take
away any of the Company’s employees or consultants either for the Consultant or for any other person or entity. 
 
16. The Company will indemnify and hold harmless Consultant from any claims or damages related to statements prepared by
or made by Consultant 

that are either approved in advance by the Company or entirely based on information
provided by the Company. 
 

	  Consultant:
  V.T. Franzke
	  	  	  	  Company:
  Calypte Biomedical Corporation

	
	  /s/    V.T. FRANZKE

	  	  	  	  By:
	  	  /s/    RICHARD D.
BROUNSTEIN            

	  V.T. Franzke
	  	  	  	  	  	  Richard Brounstein
  Executive Vice President & CFOAmended Consulting Agreement-Sadegh Panahi

 
Exhibit 4.1(g)

 
Amendment No. 2 to Consulting Agreement

Between Calypte Biomedical Corporation 
and Sadegh Panahi 
 
This Agreement amends and modifies the Consulting Agreement between Calypte Biomedical Corporation (“Calypte” or the “Company”) and Sadegh Panahi (“Consultant”) dated November 20, 2002 and is effective
as of February 14, 2003. 
 
Whereas, the Company desires to extend
the time period during which Consultant will provide services to the Company pursuant to the above referenced Consulting Agreement and Consultant is agreeable to extending the time for providing such services. 
 
Now therefore, in consideration of the premises and mutual promises set forth
herein, the parties hereto agree as follows: 
 

	  	 1.	  	 The term of Consultant’s Consulting Agreement shall be extended and, by virtue of this Amendment, shall terminate on December 31, 2003 rather than July 20,
2003. 

 

	  	 2.	  	 In consideration for the extension of the services to be performed by Consultant, the Company will immediately grant to Consultant 3,000,000 shares of its
registered common stock. The Company will also immediately grant Consultant a warrant to purchase Three million (3,000,000) shares of the common stock of the Company at an exercise price of $0.05 per share, or an aggregate purchase price of
$150,000. The warrant is immediately exercisable upon grant and will expire on November 20, 2003. All compensation pursuant to the Consulting Agreement and this Amendment is fully earned upon execution of this amendment. 

 

	  	 3.	  	 The Company at the same time is canceling its obligation to grant, subject to stockholders’ approval of the increase in shares and annual stock grant limits in
the 2000 Equity Incentive Plan, an option to purchase 3,000,000 shares of the registered common stock of the Company at $0.05 per share, or an aggregate purchase price of $150,000. The option would have been immediately exercisable upon grant and
expired on November 20, 2003. 

 

	  	 4.	  	 All other terms and conditions of the Consultant Agreement dated November 20, 2002 remain unchanged. 

 

	  Consultant:
	  	  	  	  Calypte Biomedical
Corporation       

	
	  /s/    SADEGH PANAHI

	  	  	  	  By:
	  	  /s/    RICHARD D.
BROUNSTEIN            

	  Sadegh Panahi
	  	  	  	  	  	  Richard Brounstein
  Executive Vice President & CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}]]